CYMEVAN Side Effects

6732387-9 | Haematoma, Haemorrhage, Thrombocytopenia
on May 17, 2010 Female patient from FRANCE , 58 years of age, was diagnosed with aortic valve replacement and was treated with Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, haemorrhage, thrombocytopenia. Cymevan dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6686572-5 | Haematoma, Haemorrhage, Thrombocytopenia
Patient was taking Cymevan (View Usage). Patient had the following side effects: haematoma, haemorrhage, thrombocytopenia on Apr 14, 2010 from FRANCE Additional patient health information: Female patient , 58 years of age, was diagnosed with aortic valve replacement and. Cymevan dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6185308-4 | Pyramidal Tract Syndrome
Adverse event was reported on May 04, 2009 by a Male patient taking Cymevan (View Usage) (Dosage: ) . Location: FRANCE , 15 years of age, After Cymevan was administered, patient had the following side effects: pyramidal tract syndrome. During the same period patient was treated with FORTUM (View Fortum Review and Fortum Label ), FOSCAVIR (View Foscavir Review and Foscavir Label ), TARGOCID (Route: Oral Intra-venous) (View Targocid Review and Targocid Label ). Patient was hospitalized.

5977701-7 | Pancytopenia, Sepsis, Septic Shock
on Nov 26, 2008 Male patient from FRANCE , 41 years of age, was diagnosed with infection (What is infection?) and was treated with Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, sepsis (What is sepsis?), septic shock. Cymevan dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), PROGRAF (View Prograf Review and Prograf Label ), FOSCAVIR (Dosing Regimen: 6g/25 Ml) (View Foscavir Review and Foscavir Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), SOLUPRED (View Solupred Review and Solupred Label ), XANAX (View Xanax Review and Xanax Label ), STABLON (View Stablon Review and Stablon Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.


5828926-2 | No Adverse Event
on Jul 11, 2008 Female patient from FRANCE , 89 years of age, was treated with Cymevan (View Usage). Patient had the following side effects: no adverse event. Cymevan dosage: Form: Injectable Solution..

5813363-7 | No Adverse Event
Patient was taking Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: no adverse event on Jul 11, 2008 from FRANCE Additional patient health information: Female patient , 89 years of age, . Cymevan dosage: Form: Injectable Solution..

5684976-0 | Vasculitis
Adverse event was reported on Sep 14, 1998 by a Male patient taking Cymevan (View Usage) (Dosage: ) . Location: FRANCE , 67 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: vasculitis (What is vasculitis?). During the same period patient was treated with FORTUM (View Fortum Review and Fortum Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

5567068-0 | Anaemia, Lung Neoplasm Malignant
on Aug 21, 2006 Male patient from FRANCE , 75 years of age, was treated with Cymevan (View Usage). Patient had the following side effects: anaemia, lung neoplasm malignant. Cymevan dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), PREVISCAN (View Previscan Review and Previscan Label ).

5565551-5 | Cardiovascular Disorder, Neutropenia, Renal Failure, Respiratory Distress, Sepsis
on Aug 17, 2005 Male patient from FRANCE , 68 years of age, was treated with Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: cardiovascular disorder, neutropenia, renal failure, respiratory distress, sepsis (What is sepsis?). Cymevan dosage: . Patient was hospitalized.

5525373-8 | Bone Marrow Failure
Patient was taking Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure on Nov 16, 2007 from FRANCE Additional patient health information: Male patient , 53 years of age, . Cymevan dosage: . During the same period patient was treated with FOSCAVIR (View Foscavir Review and Foscavir Label ). Patient was hospitalized.

5467190-3 | Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Vomiting
Adverse event was reported on Sep 14, 2007 by a Male patient taking Cymevan (View Usage) (Dosage: Dosage3: 350 Kiu.) . Location: FRANCE , 48 years of age, weighting 176.4 lb, Patient had the following side effects: cytolytic hepatitis, gamma-glutamyltransferase increased, vomiting. During the same period patient was treated with ROVALCYTE (View Rovalcyte Review and Rovalcyte Label ), INIPOMP (View Inipomp Review and Inipomp Label ), RIFADIN (View Rifadin Review and Rifadin Label ), RIMIFON (View Rimifon Review and Rimifon Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ). Patient was hospitalized.

5192235-8 | Bone Marrow Failure
on Oct 30, 2006 Female patient from FRANCE , 71 years of age, was treated with Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: bone marrow failure. Cymevan dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), FORTUM (View Fortum Review and Fortum Label ), LEDERFOLINE (Received Since Hospitalisation, Except For Four Days.) (View Lederfoline Review and Lederfoline Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

5146710-2 | Bone Marrow Failure
on Oct 30, 2006 Female patient from FRANCE , 71 years of age, was treated with Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure. Cymevan dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), FORTUM (View Fortum Review and Fortum Label ), LEDERFOLINE (Received Since Hospitalisation, Except For Four Days.) (View Lederfoline Review and Lederfoline Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

5135645-7 | Bradycardia, Cardiac Disorder, Haemodynamic Instability, Liver Disorder, Nervous System Disorder, Renal Disorder, Respiratory Disorder, Rhabdomyolysis, Tachycardia
Patient was taking Cymevan (View Usage). Patient had the following side effects: bradycardia, cardiac disorder, haemodynamic instability, liver disorder, nervous system disorder, renal disorder, respiratory disorder, rhabdomyolysis, tachycardia on Oct 03, 2006 from FRANCE Additional patient health information: Female patient , 40 years of age, . Cymevan dosage: . During the same period patient was treated with XIGRIS (View Xigris Review and Xigris Label ), PROGRAF (View Prograf Review and Prograf Label ), WELLVONE (View Wellvone Review and Wellvone Label ), BACTRIM (On 15 July 2006 Given At A High Dosage.) (View Bactrim Review and Bactrim Label ), IMUREL (View Imurel Review and Imurel Label ).

5126064-8 | Bradycardia, Cardiac Disorder, Encephalitis, Hepatic Failure, Nervous System Disorder, Pneumocystis Jiroveci Pneumonia, Renal Failure, Respiratory Failure, Rhabdomyolysis
Adverse event was reported on Oct 03, 2006 by a Female patient taking Cymevan (View Usage) (Dosage: ) . Location: FRANCE , 40 years of age, After Cymevan was administered, patient had the following side effects: bradycardia, cardiac disorder, encephalitis (What is encephalitis?), hepatic failure, nervous system disorder, pneumocystis jiroveci pneumonia, renal failure, respiratory failure, rhabdomyolysis. During the same period patient was treated with XIGRIS (View Xigris Review and Xigris Label ), PROGRAF (View Prograf Review and Prograf Label ), WELLVONE (View Wellvone Review and Wellvone Label ), BACTRIM (On 15 July 2006 Given At A High Dosage.) (View Bactrim Review and Bactrim Label ), IMUREL (View Imurel Review and Imurel Label ).

5096220-6 | Rash Maculo-papular, Stevens-johnson Syndrome
on Aug 23, 2006 Male patient from FRANCE , 38 years of age, was treated with Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular, stevens-johnson syndrome. Cymevan dosage: . During the same period patient was treated with TOPALGIC LP (TRAMADOL) (View Topalgic Lp (tramadol) Review and Topalgic Lp (tramadol) Label ), VFEND (View Vfend Review and Vfend Label ), TIENAM (View Tienam Review and Tienam Label ), FLAGYL (View Flagyl Review and Flagyl Label ), AMIKLIN (View Amiklin Review and Amiklin Label ). Patient was hospitalized.

4844067-5 | Bone Pain, Pyrexia
on Nov 22, 2005 Female patient from FRANCE , 49 years of age, was treated with Cymevan (View Usage). Patient had the following side effects: bone pain, pyrexia. Cymevan dosage: Form: Lyophilised. Dosage Regimen Reported As 1 Dose Every Day. During the same period patient was treated with SPASFON LYOC (Form: Lyophilised) (View Spasfon-lyoc Review and Spasfon-lyoc Label ). Patient was hospitalized.

4814876-7 | Dialysis, Nephritis Interstitial, Renal Failure Acute, Renal Failure Chronic
Patient was taking Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: dialysis (What is dialysis?), nephritis interstitial, renal failure acute, renal failure chronic on Oct 17, 2005 from FRANCE Additional patient health information: Male patient , child 11 years of age, weighting 83.78 lb, . Cymevan dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

4728831-9 | Bradycardia
Adverse event was reported on Apr 25, 2005 by a Female patient taking Cymevan (View Usage) (Dosage: Formulation Reported As Lyophilised.) was diagnosed with prophylaxis and. Location: FRANCE , child 8 years of age, weighting 46.30 lb, Patient experienced the following unwanted or unexpected effects: bradycardia. During the same period patient was treated with SOLU MEDROL (Formulation Reported As Lyophilised. Strength Reported As 20mg/2ml.) (View Solu-medrol Review and Solu-medrol Label ), AMBISOME (View Ambisome Review and Ambisome Label ), FORTUM (View Fortum Review and Fortum Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), AMIKLIN (View Amiklin Review and Amiklin Label ). Patient was hospitalized.

4651096-3 | Bradycardia
on Apr 25, 2005 Female patient from , child 8 years of age, weighting 46.30 lb, was diagnosed with prophylaxis and was treated with Cymevan (View Usage). Patient had the following side effects: bradycardia. Cymevan dosage: Formulation Reported As Lyophilised.. During the same period patient was treated with SOLU MEDROL (Formulation Reported As Lyophilised. Strength Reported As 20mg/2ml.) (View Solu-medrol Review and Solu-medrol Label ), AMBISOME (View Ambisome Review and Ambisome Label ). Patient was hospitalized.

4645029-3 | Agranulocytosis
on Feb 08, 2005 Female patient from , 39 years of age, weighting 152.1 lb, was diagnosed with renal transplant and was treated with Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: agranulocytosis. Cymevan dosage: . During the same period patient was treated with CELLCEPT (At Discharge.) (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NEORECORMON (Formulation Reported As Injectable Solution.) (View Neorecormon Review and Neorecormon Label ), FORTUM (View Fortum Review and Fortum Label ), TENORMIN (View Tenormin Review and Tenormin Label ), CORTANCYL (Dosage Regimen Reported As 60 Mg.) (View Cortancyl Review and Cortancyl Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

4617090-3 | Cholestasis, Toxic Epidermal Necrolysis
Patient was taking Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, toxic epidermal necrolysis on Feb 28, 2005 from Additional patient health information: Male patient , 55 years of age, was diagnosed with endocarditis (What is endocarditis?), aspergillosis and. Cymevan dosage: . During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), VFEND (View Vfend Review and Vfend Label ), FOSCAVIR (View Foscavir Review and Foscavir Label ), GENTAMICIN SULFATE (Trade Name Reported As Pamphara.) (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ).

4607452-2 | Toxic Epidermal Necrolysis
Adverse event was reported on Feb 28, 2005 by a Male patient taking Cymevan (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?), aspergillosis and. Location: , 55 years of age, Patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), VFEND (View Vfend Review and Vfend Label ), FOSCAVIR (View Foscavir Review and Foscavir Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ).

4596134-1 | Abscess, Agranulocytosis, Escherichia Infection, Kidney Transplant Rejection
on Feb 08, 2005 Female patient from , 39 years of age, was diagnosed with renal transplant and was treated with Cymevan (View Usage). After Cymevan was administered, patient had the following side effects: abscess (What is abscess?), agranulocytosis, escherichia infection, kidney transplant rejection. Cymevan dosage: . During the same period patient was treated with CELLCEPT (At Discharge.) (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NEORECORMON (Formulation Reported As Injectable Solution.) (View Neorecormon Review and Neorecormon Label ), FORTUM (View Fortum Review and Fortum Label ), TENORMIN (View Tenormin Review and Tenormin Label ).

4588229-3 | Abscess, Agranulocytosis, Cytomegalovirus Infection, Escherichia Infection, Kidney Transplant Rejection
on Feb 08, 2005 Female patient from , 39 years of age, was diagnosed with renal transplant and was treated with Cymevan (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?), escherichia infection, kidney transplant rejection. Cymevan dosage: . During the same period patient was treated with NEORECORMON (Formulation Reported As Injectable Solution.) (View Neorecormon Review and Neorecormon Label ), CELLCEPT (At Discharge.) (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FORTUM (View Fortum Review and Fortum Label ), TENORMIN (View Tenormin Review and Tenormin Label ).

4548362-9 | Agranulocytosis
Patient was taking Cymevan (View Usage). Patient had the following side effects: agranulocytosis on Aug 12, 2004 from Additional patient health information: Female patient , 23 years of age, was diagnosed with prophylaxis and. Cymevan dosage: . During the same period patient was treated with ROVALCYTE (View Rovalcyte Review and Rovalcyte Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLODIL (View Flodil Review and Flodil Label ). Patient was hospitalized.